Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Becker, JC; Schrama, D; .
The Dark Side of Cyclophosphamide: Cyclophosphamide-Mediated Ablation of Regulatory T Cells.
J INVEST DERMATOL. 2013; 133(6): 1462-1465.
Doi: 10.1038/jid.2013.67
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Becker Jürgen Christian
- Co-Autor*innen der Med Uni Graz
-
Schrama David
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cancer immune escape is frequently associated with the induction of an inappropriate immune response, i.e., a response that does not inhibit but perhaps even promotes the tumor. Indeed, increased frequencies of tumor-infiltrating regulatory T cells (Tregs) are associated with an impaired prognosis in several cancers. Thus, depletion of Tregs, e.g., by cyclophosphamide, was proposed as a means to boost immune responses to cancer. In the present issue of the Journal, Sevko et al., however, provide evidence that cyclophosphamide exerted the unexpected effect of induction of myeloid-derived suppressor cells.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Cyclophosphamide - pharmacology
-
Female -
-
Immunosuppression - methods
-
Melanoma - drug therapy
-
Skin Neoplasms - drug therapy
-
T-Lymphocytes, Regulatory - drug effects